Abveris acquired by Twist Bioscience

Dec. 2021

Client: Abveris is a premier therapeutic and reagent antibody discovery platform, providing services to leading biotech and pharmaceutical companies

Role: Edgemont Partners acted as exclusive financial advisor to Abveris in its sale to Twist Bioscience

Location: Canton, MA

Sector: Pharmaceutical Services

Lead Banker: David Blume

View Press Release

acquired by

Get In Touch